• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » General Psychiatry » Files

General Psychiatry

Parkinsonism

November 29, 2023

Also known as pseudoparkinsonism, these drug-induced symptoms mimic those of Parkinson’s disease: ⦁ Tremor (especially apparent in the hands as a resting, “pill rolling” tremor). ⦁ Rigidity (cog-wheel rigidity). ⦁ Bradykinesia (slow movement), decreased arm swing. ⦁ Shuffling gait. ⦁ Slurred speech. ⦁ Mask-like facies, stooped posture, drooling. ⦁ Psychological side effects, such as cognitive dulling (bradyphrenia), worse negative symptoms (neuroleptic-induced deficit syndrome), worse depression (neuroleptic dysphoria). From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DIAZEPAM (Valium) Fact Sheet [G]

November 29, 2023

Diazepam has a long history of use with good efficacy for anxiety. Its long half-life makes it a particularly effective anxiolytic for some patients, and it is a good alternative to chlordiazepoxide for alcohol withdrawal. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

MOLINDONE (Moban) Fact Sheet [G]

November 29, 2023

Molindone is an effective, well-tolerated first-generation antipsychotic of medium potency—a solid medication that some clinicians have gained experience with and favor for select patients. Recently it has been reintroduced into the market, and is still generic and inexpensive. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DOPAMINE AGONISTS (Mirapex, Neupro, Requip, Sinemet) Fact Sheet [G]

November 29, 2023

Dopamine agonists are effective first-line agents for restless legs syndrome (RLS), though rates of problematic impulsive or compulsive behaviors can be high. Reserve carbidopa/levodopa for intermittent use. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

FLUPHENAZINE (Prolixin) Fact Sheet [G]

November 29, 2023

Fluphenazine is an effective, inexpensive first-generation antipsychotic with a long history of experience and use, but clinical utility is limited in some patients due to EPS. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

ARIPIPRAZOLE (Abilify) Fact Sheet [G]

November 29, 2023

Aripiprazole is a good choice for minimizing risk of weight gain and metabolic side effects, but beware of akathisia. Large number of indications and reports of success at a variety of doses make it difficult to predict dosing for individual patients. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DEXTROAMPHETAMINE TRANSDERMAL (Xelstrym) Fact Sheet

November 29, 2023

Like Daytrana, Xelstrym is helpful for those who, for whatever reason, cannot use any of the wide variety of oral stimulant preparations. Otherwise, we don’t recommend it due to high cost, lag time for onset of effect, and the side effect of rash, which is pretty common and unpleasant. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

Bright Light Therapy Fact Sheet

November 29, 2023

Light therapy is an effective treatment for seasonal affective disorder (SAD) and possibly for nonseasonal depression as well. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DULOXETINE (Cymbalta, Drizalma Sprinkle) Fact Sheet [G]

November 29, 2023

Duloxetine is the main SNRI alternative to venlafaxine/desvenlafaxine. It has a niche for depressed patients with various comorbid pain syndromes. However, you should balance this advantage against its potentially serious (though rare) hepatic side effects. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

Prolactinemia

November 29, 2023

Elevated prolactin levels (>29 ng/mL in nonpregnant, nonlactating women, >18 ng/mL in men) that can cause the following symptoms: ⦁ Women: Menstrual irregularity or amenorrhea, infertility, lowered libido, galactorrhea, decreased bone density, increase or thickening of hair in unexpected areas such as face. ⦁ Men: Breast enlargement (gynecomastia), erectile dysfunction, low libido, infertility, galactorrhea.

Previous 1 2 … 21 22 23 24 25 26 27 28 29 30 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2603816031.jpg
    General Psychiatry

    A Scam for Every Woman, Child, and Man: Part 2

    1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.